Pharma

Call for national children's health strategy in Canada

Children's Healthcare Canada urges a strategic overhaul to prioritize and improve children's health nationwide

Call for national children's health strategy in Canada

New funding urged for PAH treatment in Canada

PHA Canada advocates for quick allocation of funds for rare disease medicines, spotlighting PAH's impact on work and life

New funding urged for PAH treatment in Canada

iA Financial Group webinar focuses on inclusive drug insurance

Explore how integrating EDI into benefit programs can enhance employee health and attract top talent

iA Financial Group webinar focuses on inclusive drug insurance

Surge in early-onset breast cancer spurs biotech innovations

Rising breast cancer cases prompt new treatment advances, with biotech firms leading breakthrough efforts

Surge in early-onset breast cancer spurs biotech innovations

Drug trends report shows where costs are rising

After releasing their annual report, experts from TELUS health discuss how plan sponsors can manage costs for their clients

Drug trends report shows where costs are rising

What can plan sponsors learn from obesity drug trends?

New research from DBRS Morningstar finds insurers balancing high upfront cost against potential for long-term savings from GLP-1 drugs